Publicaciones en las que colabora con Juan José Picazo de la Garza (37)

2016

  1. Compendio de microbiología

    Elsevier

2012

  1. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 1, pp. 167-169

2011

  1. Actividad in vitro de retapamulina frente a cepas de Staphylococcus aureus resistente a meticilina y a linezolid

    Revista Espanola de Quimioterapia, Vol. 24, Núm. 3, pp. 127-130

2010

  1. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: Pharmacodynamic and microbiological aspects

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 2, pp. 103-108

  2. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit

    JAMA - Journal of the American Medical Association, Vol. 303, Núm. 22, pp. 2260-2264

  3. Comparative activities of TR-700 (Torezolid) against staphylococcal blood isolates collected in spain

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 5, pp. 2212-2215

  4. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5352-5355

  5. Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: Epidemiology and study of patient movements

    Microbial Drug Resistance, Vol. 16, Núm. 4, pp. 309-315

  6. Paciente viajera con múltiples lesiones cutáneas de 6 meses de evolución

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 5, pp. 323-324

  7. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid resistant Staphylococcus aureus

    Clinical Infectious Diseases, Vol. 50, Núm. 6, pp. 821-825

  8. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5337-5343

2008

  1. Viajero con lesiones cutáneas diseminadas en la extremidad inferior

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 7, pp. 471-472

2004

  1. Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission

    European Neurology, Vol. 52, Núm. 2, pp. 87-91

  2. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection

    Archives of Neurology, Vol. 61, Núm. 10, pp. 1523-1527

  3. Resistencia a carbapenemes por metaloenzimas en aislamientos clínicos de Pseudomonas aeruginosa

    Revista Espanola de Quimioterapia, Vol. 17, Núm. 4, pp. 336-340

2003

  1. Prevalencia y tratamiento de las infecciones por Grampositivos en los servicios de medicina interna de hospitales Españoles: Estudio IGP

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 4, pp. 428-435

  2. Staphylococcus aureus bacteremic pneumonia: Differences between community and nosocomial acquisition

    International Journal of Infectious Diseases, Vol. 7, Núm. 2, pp. 102-108

2002

  1. Prevalence of herpesvirus DNA in MS patients and healthy blood donors

    Acta Neurologica Scandinavica, Vol. 105, Núm. 2, pp. 95-99

2001

  1. Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999 [7]

    Journal of Antimicrobial Chemotherapy

  2. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 8, pp. 2372-2374